journal article·2025-10-08Open access

Hybrid Silver–Silica and Organic Biocide Systems in PVC: Enhanced Antiviral Performance against SARS-CoV-2

Daniel J. da Silva, Guilherme B. Gramcianinov, Vanessa B. Malaquias, Pamela Z. Jorge, Cecilia Gonsales, Eduardo W. A. Pereira, Leice G. Amurin, Mário Hiroyuki Hirata, Caroline C. Augusto, Bruno L. Batista, Beatriz B. Alves, Luciano A. Bueno, Danilo J. Carastan, Mathilde Champeau

ACS Applied Materials & Interfaces· Volume 17· Issue 40

Abstract

High Resolution Image Download MS PowerPoint Slide Poly(vinyl chloride) (PVC) is widely used in biomedical devices and hospital infrastructure. In light of emerging pathogens such as SARS-CoV-2, there is a growing need for PVC materials with intrinsic antiviral properties. This study presents an effective strategy to develop antiviral PVC nanocomposites by incorporating silver–silica (Ag/SiO 2 ) hybrid nanoparticles via melt processing. Two hybrid nanoparticle systems were incorporated: SiO 2 decorated with silver nanoparticles and a mixture of Ag/SiO 2 with two organic biocides (triclosan and zinc pyrithione). Comprehensive morphological, optical, thermal, and mechanical characterizations were conducted to assess structure–property relationships, along with antiviral tests against SARS-CoV-2. The addition of Ag/SiO 2 nanoparticles preserved the PVC thermal stability and impact strength, whereas it increased the stiffness. The particles containing the biocides limited PVC discoloration but affected the mechanical properties due to their plasticizing effect. Whereas a concentration of 2.5 wt % of Ag/SiO 2 nanoparticles inactivated SARS-CoV-2, only 0.5 wt % of the Ag/SiO 2 /organic biocide system was necessary, showing a combined virucidal response between Ag on the nanocomposite surface and triclosan that is released. Excessive filler content led to performance drops or cytotoxic effects. The combination of inorganic and organic antimicrobial agents enables tailored functionality, demonstrating the potential of these materials for use in medical devices, personal protective equipment, and surfaces requiring antimicrobial protection.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoparticles: synthesis and applications · SARS-CoV-2 detection and testing · Recycling and Waste Management Techniques

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Center for Engineering, Modeling and Applied Social Sciences (CECS), Federal University of ABC (UFABC), Av. dos Estados, 5001, Santo André, SP CEP 09210-580, Brazil

Department of Clinical and Toxicological Analysis, Faculty of Pharmaceutical Sciences, University of São Paulo, Av. Professor Lineu Prestes, 580, São Paulo, SP CEP 05508-900, Brazil

Center for Natural and Human Sciences (CCNH), Federal University of ABC (UFABC), Av. dos Estados, 5001, Santo André, SP CEP 09210-580, Brazil

BR Goods Indústria e Comércio de Produtos Hospitalares, R. Antônio Barnabé, 1398, Indaiatuba, SP CEP: 13347-340, Brazil

Funding

Conselho Nacional de Desenvolvimento Cient?fico e Tecnol?gico · Funda??o de Amparo ? Pesquisa do Estado de S?o Paulo · Financiadora de Estudos e Projetos · Coordena??o de Aperfei?oamento de Pessoal de N?vel Superior

References (69)

Show source-provided references
1. 10.1038/s41576-021-00408-x10.1038/s41576-021-00408-x ↗
2. 10.3389/fcell.2020.0061810.3389/fcell.2020.00618 ↗
3. 10.1021/acsbiomaterials.0c0034810.1021/acsbiomaterials.0c00348 ↗
4. 10.1073/pnas.201456411810.1073/pnas.2014564118 ↗
5. 10.1007/s10924-021-02272-610.1007/s10924-021-02272-6 ↗
6. Scientific Committee on Health Environmental and Emerging Risks (SCHEER) · 2024
7. 10.1016/j.jtusci.2014.09.00710.1016/j.jtusci.2014.09.007 ↗
8. 10.1007/s10853-018-2206-710.1007/s10853-018-2206-7 ↗
9. Mark H. F. · 2004
10. 10.1038/s43246-021-00153-y10.1038/s43246-021-00153-y ↗
11. Vodnar D. C. · 2020 · 46510.1016/B978-0-12-815882-1.00011-2 ↗
12. 10.1080/10601325.2016.116600010.1080/10601325.2016.1166000 ↗
13. 10.1016/j.fpsl.2017.12.00510.1016/j.fpsl.2017.12.005 ↗
14. 10.3390/polym1621302810.3390/polym16213028 ↗
15. 10.1007/s10965-021-02729-110.1007/s10965-021-02729-1 ↗
16. 10.3389/fchem.2023.108339910.3389/fchem.2023.1083399 ↗
17. 10.3390/microorganisms1103062910.3390/microorganisms11030629 ↗
18. 10.1016/j.jcis.2009.03.01810.1016/j.jcis.2009.03.018 ↗
19. 10.1007/s10971-018-4724-910.1007/s10971-018-4724-9 ↗
20. 10.1016/j.oceram.2020.10000610.1016/j.oceram.2020.100006 ↗
21. 10.1016/j.jcis.2016.08.03910.1016/j.jcis.2016.08.039 ↗
22. 10.1080/14756366.2022.210841710.1080/14756366.2022.2108417 ↗
23. 10.1021/acsami.1c1411310.1021/acsami.1c14113 ↗
24. 10.3390/polym1505123610.3390/polym15051236 ↗
25. 10.1007/s11356-021-17273-010.1007/s11356-021-17273-0 ↗
26. 10.1590/0104-1428.0821810.1590/0104-1428.08218 ↗
27. 10.1016/j.cherd.2018.03.01910.1016/j.cherd.2018.03.019 ↗
28. 10.3390/nano1103063810.3390/nano11030638 ↗
29. 10.1016/j.optmat.2011.12.01910.1016/j.optmat.2011.12.019 ↗
30. 10.1007/s12250-020-00230-510.1007/s12250-020-00230-5 ↗
31. 10.1023/A:101007222673710.1023/A:1010072226737 ↗
32. 10.1016/j.colsurfb.2013.10.02910.1016/j.colsurfb.2013.10.029 ↗
33. 10.3390/bioengineering404008110.3390/bioengineering4040081 ↗
34. 10.1590/1980-5373-mr-2017-073410.1590/1980-5373-mr-2017-0734 ↗
35. 10.1590/0104-6632.20190364s2019013910.1590/0104-6632.20190364s20190139 ↗
36. Bruice P. Y. · 2006
37. 10.1016/j.cdc.2018.10017510.1016/j.cdc.2018.100175 ↗
38. 10.1590/1980-5373-mr-2017-013710.1590/1980-5373-mr-2017-0137 ↗
39. 10.1590/0104-1428.2023010010.1590/0104-1428.20230100 ↗
40. 10.1016/j.jpba.2010.12.00910.1016/j.jpba.2010.12.009 ↗
41. 10.1177/15589250209401010.1177/155892502094010 ↗
42. 10.1016/j.cej.2021.13134410.1016/j.cej.2021.131344 ↗
43. 10.1002/app.4666010.1002/app.46660 ↗
44. 10.1002/pc.2423210.1002/pc.24232 ↗
45. 10.1177/875608791561288410.1177/8756087915612884 ↗
46. 10.1016/j.wear.2015.02.01310.1016/j.wear.2015.02.013 ↗
47. Blitz J. P. · 1998 · 185
48. 10.1016/j.powtec.2015.05.03910.1016/j.powtec.2015.05.039 ↗
49. 10.1007/s00339-019-2770-y10.1007/s00339-019-2770-y ↗
50. Munir T. · Dig. J. Nanomater. Biostruct. · 2019 · 14 · 279
51. 10.1088/1742-6596/764/1/01201910.1088/1742-6596/764/1/012019 ↗
52. 10.30492/ijcce.2013.573910.30492/ijcce.2013.5739 ↗
53. 10.1016/j.polymdegradstab.2010.12.00110.1016/j.polymdegradstab.2010.12.001 ↗
54. 10.1002/vnl.2001310.1002/vnl.20013 ↗
55. 10.1002/app.4100110.1002/app.41001 ↗
56. 10.1002/vnl.2021110.1002/vnl.20211 ↗
57. Langlois W. E. · 2014 · 22910.1007/978-3-319-03835-3_9 ↗
58. 10.1590/1980-5373-MR-2016-023910.1590/1980-5373-MR-2016-0239 ↗
59. 10.1021/acs.jpca.5b0239310.1021/acs.jpca.5b02393 ↗
60. 10.1016/j.aej.2023.03.07110.1016/j.aej.2023.03.071 ↗
61. 10.1007/s10854-023-11304-x10.1007/s10854-023-11304-x ↗
62. 10.3390/nano1307126210.3390/nano13071262 ↗
63. 10.1556/1326.2017.0028610.1556/1326.2017.00286 ↗
64. 10.3390/ma1409227010.3390/ma14092270 ↗
65. 10.1002/gch2.20240038010.1002/gch2.202400380 ↗
66. 10.1021/acsami.4c1528910.1021/acsami.4c15289 ↗
67. 10.1016/j.lwt.2018.11.08210.1016/j.lwt.2018.11.082 ↗
68. 10.1016/j.mtcomm.2024.11010910.1016/j.mtcomm.2024.110109 ↗
69. 10.3389/fmicb.2024.146305610.3389/fmicb.2024.1463056 ↗